OliX Pharmaceuticals Receives HREC Approval to Initiate Phase 1 Clinical Trial of NASH and Obesity Drug
SUWON, South Korea--(BUSINESS WIRE)--#AMD--OliX Pharmaceuticals, Inc. (KOSDAQ: 226950), a leading developer of RNAi therapeutics, today…
SUWON, South Korea--(BUSINESS WIRE)--#AMD--OliX Pharmaceuticals, Inc. (KOSDAQ: 226950), a leading developer of RNAi therapeutics, today…
DUBLIN--(BUSINESS WIRE)--The "Japan Games Market Report" report from Niko Partners, Inc. has been added to…
TAIPEI, TAIWAN - Media OutReach Newswire - 22 December 2023 - The highly anticipated Taiwan…
KUALA LUMPUR, Malaysia--(BUSINESS WIRE)--#CrisisCommunication--The Crisis Management Centre foresees that 2024 will carry with it increased…
U.S. label update includes superior progression-free survival results from the Phase 3 ALPINE head-to-head trial…
BEIJING, CHINA - Media OutReach Newswire - 22 December 2023 - From the Adama Wind…
SHENZHEN, China--(BUSINESS WIRE)--VOOPOO is excited to announce the arrival of the VOOPOO DRAG X2, DRAG…
HONG KONG SAR - Media OutReach Newswire - 22 December 2023 - KPMG China recently…
HONG KONG SAR - Media OutReach Newswire - 22 December 2023 - The Centre on…
SINGAPORE - Media OutReach Newswire - 22 December 2023 - FBS, a global trading platform,…